US 12186378
Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists
granted A61KA61K31/165A61K31/198
Quick answer
US patent 12186378 (Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/165, A61K31/198, A61K38/51, A61P